Healios K.K. (OTCMKTS:HLOSF) Sees Large Increase in Short Interest

Healios K.K. (OTCMKTS:HLOSF) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 50,500 shares, a growth of 4,490.9% from the September 30th total of 1,100 shares. Based on an average daily trading volume, of 200 shares, the days-to-cover ratio is presently 252.5 days.

Healios K.K. Stock Performance

HLOSF opened at 1.50 on Friday. The firm’s 50 day simple moving average is 1.59 and its two-hundred day simple moving average is 1.27. Healios K.K. has a 1-year low of 0.93 and a 1-year high of 1.73.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.